Results 1 to 10 of about 5,917,133 (304)
Type 2 Diabetes in Youth [PDF]
Global Pediatric Health, 2020 The incidence of type 2 diabetes in children and adolescents in the United States rose at an annual rate of 4.8% between 2002-2003 and 2014-2015. Type 2 diabetes progresses more aggressively to complications than type 1 diabetes.
Goutham Rao MD, Elizabeth T. Jensen PhD
doaj +4 more sources
Sugar and Type 2 diabetes [PDF]
British Medical Bulletin, 2016 Background: Consumption of sugar, specifically sugar-sweetened beverages, has been widely held responsible by the media for the global rise in Type 2 diabetes (T2DM).
Lean, Michael E.J., Te Morenga, Lisa
core +5 more sources
The Lancet, 2018 The purpose of this two page educational document is to inform not only educators, but also students about the description of type two diabetes and what populations are affected, the epidemiology of type 2 diabetes, including how get diagnosed and how ...
Mimlitz, AJ
core +7 more sources
Annals of Internal Medicine, 2020 Diabetes affects the patient in a myriad of ways ranging from the patient\u27s physical, social, mental, and financial health. The signs and symptoms of diabetes and the complications associated with it undermine the patient\u27s level of health and well
Gebre, Zenebu
core +4 more sources
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [PDF]
New England Journal of Medicine, 2016 Background The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. Methods In this double-blind trial, we randomly assigned patients with type 2 diabetes
Bergenstal, RM +15 more
core +2 more sources
Tirzepatide for type 2 diabetes
Drugs in Context, 2023 One in ten adults worldwide is living with diabetes, with 95% having type 2 diabetes (T2D). Sustained glycaemic control in people with T2D is difficult to achieve despite recent advances in T2D management with the advent of glucagon-like peptide 1 ...
Sarah L Anderson, Joel C Marrs
doaj +3 more sources
Saxagliptin for type 2 diabetes
Diabetes, Metabolic Syndrome and Obesity, 2010 Antonio R Chacra, MDDiabetes Center, Federal University of São Paulo, BrazilAbstract: Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving glycemic control in ...
Antonio R Chacra, MD
doaj +7 more sources
Psychometric validation of type 2 Diabetes Distress Assessment System in an Indian type 2 diabetes population [PDF]
Scientific ReportsDiabetes distress (DD) significantly burdens and negatively impacts self-management and health outcomes in patients with type 2 diabetes (T2D). Early detection and management of DD are crucial for effective T2D management.
Baby Sharma +6 more
doaj +2 more sources
Biomarkers for type 2 diabetes
Molecular Metabolism, 2019 Background: The prevalence and incidence of type 2 diabetes (T2D), representing >90% of all cases of diabetes, are increasing rapidly worldwide.
Markku Laakso
doaj +3 more sources